Cirrhosis Is Associated With High Mortality and Readmissions Over 90 Days Regardless of COVID-19: A Multicenter Cohort
Liver Transpl
.
2021 Sep;27(9):1343-1347.
doi: 10.1002/lt.25981.
Epub 2021 Mar 15.
Authors
Jasmohan S Bajaj
1
2
,
Guadalupe Garcia-Tsao
3
,
Florence Wong
4
,
Scott W Biggins
5
,
Patrick S Kamath
6
,
Sara McGeorge
1
,
Michael Chew
3
,
Meredith Pearson
5
,
Jawaid Shaw
1
2
,
Anita Kalluri
7
,
Andrew Fagan
2
,
Amy Olofson
6
,
Maryam Moini
4
,
Randolph de la Rosa Rodriguez
3
,
K Rajender Reddy
7
Affiliations
1
Department of Medicine, Virginia Commonwealth University, Richmond, VA.
2
Department of Medicine, Central Virginia Veterans Healthcare System, Richmond, VA.
3
Department of Medicine, Yale University Medical Center, New Haven, CT.
4
Department of Medicine, University of Toronto, Toronto, ON, Canada.
5
Department of Medicine, University of Washington, Seattle, WA.
6
Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN.
7
Department of Medicine, University of Pennsylvania, Philadelphia, PA.
PMID:
33427401
PMCID:
PMC8014819
DOI:
10.1002/lt.25981
No abstract available
Publication types
Multicenter Study
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19*
Humans
Liver Cirrhosis / epidemiology
Liver Transplantation*
Patient Readmission
SARS-CoV-2
Grants and funding
P30 DK034989/DK/NIDDK NIH HHS/United States
UL1 TR001863/TR/NCATS NIH HHS/United States